Menu
Search for
Log In
Topics
AI & Technology
Agentic
Analytics
Automation
Blockchain
Cloud
Computer Vision
Conversational AI
Cyber Security
Data
Digital Transformation
Ethics & Responsibility
Future of AI
IoT
Machine Learning
Metaverse
Natural Language Processing (NLP)
Responsible AI
Robotics
Sectors & Use Cases
Automotive
Education
Energy
Finance
Gaming
Healthcare
Insurance
Manufacturing
Property & Real Estate
Public Sector
Retail
Sports
Supply Chain & Logistics
Telecommunications
AI Business Strategy
Digital Transformation
Environment & Sustainability
Ethics & Responsibility
HR, Workforce, and Skills
Legal & Compliance
Marketing & Customer
Product & Revenue
Policy & Regulation
AI Leadership & Perspective
Boardroom & Governance
C-Suite Perspective
Community Voices
Founder & Investor Voices
Innovation Spotlight
Interview
Leadership Vision
Strategic Partnerships
Columnists
The Control Layer By Victor Dey
Learn
Events
Newsletter
Reports & Guides
Webinars
Media Kit
Premium
Login
Contact Us
Search for
Home
/
Press release
Press release
Cision PR Newswire
7 days ago
0
Trinasolar Retains Tier 1 Status for Both PV Modules and Energy Storage Systems on S&P Global Cleantech Companies List 2026
Read More »
Cision PR Newswire
7 days ago
0
Saab signs long-term agreement for camouflage systems with the Netherlands
Read More »
Cision PR Newswire
7 days ago
0
Alleima strengthens long-standing partnership with Airbus
Read More »
Business Wire
7 days ago
TotalEnergies Completes the Transfer of its 10% Interest in Arctic LNG 2
Read More »
Cision PR Newswire
7 days ago
0
Gaotu Techedu Announces Second Quarter 2026 Unaudited Financial Results
Read More »
Cision PR Newswire
7 days ago
0
RoboSense Reports 2026 Interim Results, with Robotics LiDAR Sales Volume Up 510.4% Year over Year
Read More »
Cision PR Newswire
7 days ago
0
SCP Standard Capital Partners AG: VANEA Defence unveils ATOMZA®, the first production-ready drone defence system for civilian operators
Read More »
Cision PR Newswire
7 days ago
0
AbbVie Submits Regulatory Application to EMA for SKYRIZI® (risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn’s Disease
Read More »
Cision PR Newswire
7 days ago
0
TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS
Read More »
Cision PR Newswire
7 days ago
0
MindMaze Therapeutics Reports 2026 Half-Year Results and Corporate Update
Read More »
Previous page
Next page
Back to top button
Close
Search for
Close
Search for
Close
Log In
Forget?
Remember me
Log In